DAVID NATAN - 02 Jan 2025 Form 3 Insider Report for Cyclacel Pharmaceuticals, Inc. (CYCC)

Role
Director
Signature
/s/ David Natan
Issuer symbol
CYCC
Transactions as of
02 Jan 2025
Transactions value $
$0
Form type
3
Filing time
07 Jan 2025, 19:06:08 UTC
Previous filing
01 Oct 2024
Next filing
28 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CYCC Common Stock 0 02 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 No securities are beneficially owned.